# Oxaliplatin

## Orectalip inj 50mg/10mL

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IORE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 適應症     | Adjuvant treatment of stage III colon cancer after complete resection of primary tumor and advanced colorectal cancer (in combination with infusional fluorouracil and leucovorin).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量   | [Adjuvant therapy] 85 mg/m2 administered intravenously every 2 weeks for up to 12 cycles. [Colorectal cancer (advanced)] 85 mg/m2 on day 1 every 2 weeks until disease progression or unacceptable toxicity. [Gastric cancer] 130 mg/m2 every 3 weeks (either 130 mg/m2 on day 1 or 65 mg/m2 on day 1 and day 8). Administer oxaliplatin before fluoropyrimidine (ie., 5-fluorouracil) when coadministration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 禁忌       | Hypersensitivity to oxaliplatin, other platinum-containing compounds, or any component of the formulation. Pregnancy, breast-feeding; severe renal impairment (CrCl <30 mL/minute)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 副作用     | Nausea, vomiting, diarrhea; anemia, leucopenia, granulocytopenia, thrombocytopenia; peripheral neuropathies; fever, rash, anorexia. Gastrointestinal: Abdominal pain (monotherapy, 31%; combination therapy, up to 39% ), Constipation (combination therapy, up to 32% ), Diarrhea (monotherapy, 46%; combination therapy, up to 76% ), Loss of appetite (monotherapy, 20%; combination therapy, up to 35% ), Nausea (monotherapy, 64%; combination therapy, up to 83% ), Stomatitis (monotherapy, 14%; combination therapy, up to 42% ), Vomiting (monotherapy, 4%; combination therapy, up to 64% ) Hematologic: Anemia (monotherapy, 64%; combination therapy, up to 81% ), Neutropenia, All grades (monotherapy, 7%; combination therapy, up to 81% ) Musculoskeletal: Backache Respiratory: Cough (monotherapy, 11%; combination therapy, up to 35% ) Other: Fatigue (monotherapy, 61%; combination therapy, up to 70% ), Fever (monotherapy, 25%; combination therapy, up to 29% ) |
| 孕期建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

